Home
LaNova Medicines

LaNova Medicines Market Share Analysis for June 2026

礼新医药官网

Industry: N/A

Domainlanovamedicines.com

Year Founded--

Employees51 - 200

Annual Revenue--

LaNova Medicines

LaNova Medicines (including company regionals)

lanovamedicines.com

See more website traffic and engagement information

Total visits to LaNova Medicines's top domains

Understand LaNova Medicines market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

lanovamedicines.com631

See more with Sales Intelligence

Avg. visit duration in LaNova Medicines's top domains

Analyze LaNova Medicines engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

lanovamedicines.com--

See more with Sales Intelligence

Avg. pageviews on LaNova Medicines's top domains

See how LaNova Medicines keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

lanovamedicines.com1.13

See more with Sales Intelligence

LaNova Medicines top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by LaNova Medicines

These are the website technologies, by industry, used by LaNova Medicines top domains

Advertising (1)

PubMatic

Conversion & Analytics (1)

CNZZ

Mobile (1)

Meta Viewport

Payment & Currencies (1)

Cart Functionality

News & Signals from LaNova Medicines

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLaNova Medicines Limited attends event AACR Annual Meeting 2026.Sino Biopharmaceutical Limited announced that its subsidiary, LaNova Medicines, presented Phase 1/2 clinical data for its tetravalent bispecific antibody at the AACR Annual Meeting 2026.

NewsSinobiopharm acquires LaNova Medicines Limited for $501M.The net payment made by Sino to acquire LaNova will be approximately $500.9m, a figure that excludes the estimated cash and bank deposits, according to a company document outlining the terms of the transaction.

NewsGI Innovation Inc. partnered with LaNova Medicines Limited on Jan 22nd '25.SEOUL, South Korea, Jan. 22, 2025 /PRNewswire/ - GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination therapy.